← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 4, 2018Last known activity
Aug 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 10 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT07114419Lead sponsorPhase 2Aug 1, 2025
- NCT06900075Lead sponsorPhase 3Jul 30, 2025
- NCT06921486Lead sponsorPhase 2/Phase 3Mar 31, 2025
- NCT06849843Lead sponsorPhase 2Dec 18, 2024
- NCT06732960Lead sponsorPhase 2Apr 21, 2024
- NCT05694221Lead sponsorPhase 1Feb 1, 2023
- NCT04998032Lead sponsorPhase 2/Phase 3Oct 12, 2021
- NCT04994288Lead sponsorPhase 2/Phase 3Sep 13, 2021
- NCT04314622Lead sponsorPhase 2Apr 14, 2020
- NCT03745885Lead sponsorPhase 1Dec 4, 2018
Details
- Last known activity
- Aug 1, 2025